MAPT and Alzheimer disease: <b>Conclusion:</b> Although lacking neuropathological examination to distinguish CTE from a variant of AD, the clear demonstration of a CTE-like tau pattern in a single at-risk individual suggests further research on the potential of <sup>18</sup>F-MK6240 PET for identifying CTE is warranted.